搜索結果

...* or RFFIT* (Positive at ≥0.5IU/mL) Ehrlichia canis IFAT (Negative at 1:40) Leishmania infantum IFAT* or ELISA * (Negative) [*Strike through as required] *Leptospira sv. Canicola (if tested) [*Strike through as required] MAT (Negative at 1:100) *Brucella canis (if not desexed) RSAT* or TAT* or IFAT...

... Neutralising Antibody Titre Test (RNATT) •blood sample must be taken at least 30 days after the primary rabies vaccination •blood sampling date must not be less than 90 days and not more than 1 year prior to export •RNATT must be done by an AFCD approved laboratory, with a satisfactory result of ≥ 0.5IU/ml...

... trend. Nonetheless, the population of White-bellied Sea Eagles in Hong Kong seems healthy. Table 1. Summary of White-bellied Sea Eagles breeding from �00�/0� to �008/09. 2002/03 2003/04 2004/05 2005/06 2006/07 2007/08# 2008/09* No. of active breeding pairs 8 6 11 9 12 7 8 No. of successful breeding...

... trend. Nonetheless, the population of White-bellied Sea Eagles in Hong Kong seems healthy. Table 1. Summary of White-bellied Sea Eagles breeding from �00�/0� to �008/09. 2002/03 2003/04 2004/05 2005/06 2006/07 2007/08# 2008/09* No. of active breeding pairs 8 6 11 9 12 7 8 No. of successful breeding...

... trend. Nonetheless, the population of White-bellied Sea Eagles in Hong Kong seems healthy. Table 1. Summary of White-bellied Sea Eagles breeding from �00�/0� to �008/09. 2002/03 2003/04 2004/05 2005/06 2006/07 2007/08# 2008/09* No. of active breeding pairs 8 6 11 9 12 7 8 No. of successful breeding...

... trend. Nonetheless, the population of White-bellied Sea Eagles in Hong Kong seems healthy. Table 1. Summary of White-bellied Sea Eagles breeding from �00�/0� to �008/09. 2002/03 2003/04 2004/05 2005/06 2006/07 2007/08# 2008/09* No. of active breeding pairs 8 6 11 9 12 7 8 No. of successful breeding...

... Control Use □ 其他 Others ** 請在適當的空格內加上“”號 Please tick as appropriate (1)如活性成分多於一種，請以符號“／”分隔每種成分的相關資料 (例如：A/B/C)。 If there is more than one active ingredient, please use the symbol “/ ” to separate the related information for each ingredient (e.g. A/B/C). (2)有關劑型類別及縮寫，請參閱漁農自然護理署網頁。 Please refer to AFCD’s...

... Control Use □ 其他 Others ** 請在適當的空格內加上“”號 Please tick as appropriate (1)如活性成分多於一種，請以符號“／”分隔每種成分的相關資料 (例如：A/B/C)。 If there is more than one active ingredient, please use the symbol “/ ” to separate the related information for each ingredient (e.g. A/B/C). (2)有關劑型類別及縮寫，請參閱漁農自然護理署網頁。 Please refer to AFCD’s...

... Control Use □ 其他 Others ** 請在適當的空格內加上“”號 Please tick as appropriate (1)如活性成分多於一種，請以符號“／”分隔每種成分的相關資料 (例如：A/B/C)。 If there is more than one active ingredient, please use the symbol “/ ” to separate the related information for each ingredient (e.g. A/B/C). (2)有關劑型類別及縮寫，請參閱漁農自然護理署網頁。 Please refer to AFCD’s...

... Control Use □ 其他 Others ** 請在適當的空格內加上“”號 Please tick as appropriate (1)如活性成分多於一種，請以符號“／”分隔每種成分的相關資料 (例如：A/B/C)。 If there is more than one active ingredient, please use the symbol “/ ” to separate the related information for each ingredient (e.g. A/B/C). (2)有關劑型類別及縮寫，請參閱漁農自然護理署網頁。 Please refer to AFCD’s...